The rates of all-cause mortality in diabetes patients declined from the 1970s through the 1980s and 1990s. Researchers said pioglitazone helped reduce the risk of death, myocardial infarction and stroke in patients, while metformin was associated with a lower risk of cardiovascular disease. Presented at the ADA 73rd Scientific Sessions
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.